Concepedia

Author

Rong Feng

Synergy Pharmaceuticals (United States)

Also Known As

F Rong, F. RONG, Feng Rong, Feng, Rong, Rong Feng, Rong, Feng

31

Publications

350

Citations

8

H-Index

37

Concepts

All Affiliations

Synergy Pharmaceuticals (United States)Yangtze University
RF

About

Rong Feng is an author at Synergy Pharmaceuticals (United States) specializing in medicine, cancer cell biology, and cancer biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

141

2

Cell Biology

2

2

29

3

Engineering

1

1

20

4

Language Studies

1

1

20

5

Data Science

1

1

20

Rong Feng

×

6

Publications

202

Citations

6

H-Index

YearCitations

Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses

Kunwar Shailubhai, Stephen Comiskey, John A. Foss,

Digestive Diseases and Sciences

2013

97

<p>MALAT1 Promotes Cell Tumorigenicity Through Regulating miR-515-5p/EEF2 Axis in Non-Small Cell Lung Cancer</p>

Rong Feng, Liang Liu, Can Zou,

Cancer Management and Research

2020

41

Enhancing aspect-based sentiment analysis with BERT-driven context generation and quality filtering

Chuanjun Zhao, Rong Feng, Xuzhuang Sun,

Natural Language Processing Journal

2024

20

Circ‐SNAP47 (hsa_circ_0016760) and miR‐625‐5p are regulators of WEE1 in regulation of chemoresistance, growth and invasion of DDP‐tolerant NSCLC cells via ceRNA pathway

Can Zou, Rong Feng, Yan Zeng,

Environmental Toxicology

2021

17

Plecanatide, a Guanylate Cyclase C Agonist, Improves Bowel Habits and Symptoms Associated with Chronic Constipation in a Phase IIa Clinical Study

Kunwar Shailubhai, Laura Barrow, C. Talluto,

The American Journal of Gastroenterology

2011

15

Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5)

Dong Wei, Jing Zeng, Rong Feng,

Bioengineered

2022

12

Page 1